Study of a Unani Formulation in Body pain after fever.

Effect of Majoone Chobchini in Post Chikungunya Arthralgia â?? A Randomized placebo control study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/02/011836

Enrollment

Registered

2018-02-09

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Post Chikungunya Arthralgia

Interventions

Intervention1: Majoone Chobchini: 5gm twice a day orally with water after meal for 30 days Control Intervention1: Placebo: 5gm twice a day orally with water after meal for 30 days

Eligibility

Inclusion criteria

Inclusion criteria: Either gender Patients age between >18â?? Clinically diagnosed cases of arthralgia / arthritis followed chikungunya infection Complain of multiple joint pain for more than 3 months with history of Chikungunya fever

Exclusion criteria

Exclusion criteria: Age 60 Multiple joint pain due to other than Chikungunya infection All systemic and metabolic diseases

Design outcomes

Primary

Measure	Time frame
VAS (Visual Analogue Scale) DAS-28 (Disease Activity Scale)7 HAQ (Health Assessment Questionnaire) 7,26 ESR CRP Timepoint: VAS (Visual Analogue Scale) DAS-28 (Disease Activity Scale)7 HAQ (Health Assessment Questionnaire) 7,26 ESR CRP	—

Secondary

Measure	Time frame
Pain in joints Swelling in joints Difficulty in movement Moving stiffness of joints Timepoint: Before treatment, 8th, 15th , 22rd and 30th day	—

Countries

India

Contacts

Public ContactArisha Shahid

National Institute of Unani Medicine

drmaquamri@gmail.com9341072974

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026